Pfizer
PFE
PFE
3,141 hedge funds and large institutions have $201B invested in Pfizer in 2022 Q2 according to their latest regulatory filings, with 129 funds opening new positions, 1,398 increasing their positions, 1,257 reducing their positions, and 121 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
3,141
Holders Change
-38
Holders Change %
-1.2%
% of All Funds
53.11%
Holding in Top 10
251
Holding in Top 10 Change
+86
Holding in Top 10 Change %
+52.12%
% of All Funds
4.24%
New
129
Increased
1,398
Reduced
1,257
Closed
121
Calls
$2.9B
Puts
$2.89B
Net Calls
+$15.7M
Net Calls Change
+$69.3M
Top Buyers
| 1 |
Capital World Investors
Los Angeles,
California
|
+$1.59B |
| 2 |
BlackRock
New York
|
+$1.42B |
| 3 |
Morgan Stanley
New York
|
+$1.32B |
| 4 |
Capital International Investors
Los Angeles,
California
|
+$572M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$492M |
Top Sellers
| 1 |
D.E. Shaw & Co
New York
|
-$366M |
| 2 |
Renaissance Technologies
New York
|
-$311M |
| 3 |
Franklin Resources
San Mateo,
California
|
-$303M |
| 4 |
Barclays
London,
United Kingdom
|
-$216M |
| 5 |
1832 Asset Management
Toronto,
Ontario, Canada
|
-$198M |